| abstract |
The present invention provides antibodies that specifically bind CD123. The present invention also relates to immunoconjugates (such as antibody-drug conjugates or ADCs) comprising such antibodies, antibodies encoding nucleic acids, and methods for obtaining such antibodies. The invention also relates to therapeutic methods for using these antibodies and ADCs for the treatment of conditions associated with cells expressing CD123 (eg, cancer or autoimmune diseases). |